Crossmark

Metformin Impact on Maternal and Infant Cardiometabolic Health (MIMICH), an open-label randomised controlled trial, and Metformin Impact on Maternal and Cardiometabolic Health After Pregnancy (MIMICH II)

Crossref DOI link: https://doi.org/10.1186/s13063-025-09154-5

Published Online: 2025-10-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amica-Carpenter, Anya

Cox, David Richard https://orcid.org/0009-0003-3512-1486
Sylvestre, Yvonne

Roberts, Stephen A.

Perchard, Reena

Calloway, Eleasha

Richardson, Kerrie

Myers, Jenny
Funding

Funding for this research was provided by:

H2020 European Research Council (865792)
License Information

Text and Data Mining valid from 2025-10-17

Version of Record valid from 2025-10-17
More Information

Article History

Received: 17 October 2024

Accepted: 15 September 2025

First Online: 17 October 2025

Declarations

:

: MIMICH has been approved by the London-Chelsea REC (REC reference 21/LO/0462) and HRA. Written, informed consent to participate is obtained from all participants and is obtained by an appropriately trained healthcare professional on the study team with delegated authority.

: Not applicable.

: None.

Document is current

Any future updates will be listed below